M. Zarbin
Ophthalmology · 2004–2009
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Ophthalmology — 19 citations into it; #87 of 222 by trust here, #153 by citations
Whom M. Zarbin trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Zarbin overall
Papers from M. Zarbin's perspective
Ordered by how strongly the researchers M. Zarbin trusts endorse each paper. Same corpus, a different order for every researcher.
- A role for local inflammation in the formation of drusen in the aging eye. (American journal of ophthalmology-glaucoma)
- Pegaptanib for neovascular age-related macular degeneration. (New England Journal of Medicine)
- Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease (The FASEB Journal)
- An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice (Nature Medicine)
- VEGF receptor signalling ? in control of vascular function (Nature reviews. Molecular cell biology)
- Tight junction proteins. (Progress in Biophysics and Molecular Biology)
- A central role for inflammation in the pathogenesis of diabetic retinopathy (The FASEB Journal)
- Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. (Experimental Eye Research)
- Inflammation and Alzheimer's disease. (Neurobiology of Aging)
- Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. (Glycobiology)
Their papers
- Diabetic macular edema: pathogenesis and treatment. (2009) — 594 citations
- Current concepts in the pathogenesis of age-related macular degeneration. (2004) — 1,044 citations